Black Children With Asthma More Likely to Receive Bronchodilators From EMS
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Oct. 11, 2023 -- Black children receiving emergency medical services (EMS) care are more likely to receive a bronchodilator than White children, according to a study published online Sept. 25 in Prehospital Emergency Care.
Sylvia Owusu-Ansah, M.D., from the University of Pittsburgh, and colleagues characterized differences in prehospital treatment and transport of children with suspected asthma exacerbations by race and ethnicity. The analysis included 5,266 EMS encounters among children (aged 2 to 17 years) with asthma and wheezing identified using a national prehospital database (2019).
The researchers found that in adjusted analyses, Black non-Hispanic children were less likely to be transported compared with White non-Hispanic children (adjusted odds ratio, 0.75). At least one bronchodilator was administered by EMS to 81 percent of Black non-Hispanic patients, 73 percent of Hispanic patients, and 68 percent of White non-Hispanic patients. EMS bronchodilator administration was greater for Black non-Hispanic children (adjusted odds ratio, 1.55) than White non-Hispanic children after controlling for socioeconomic status and potential confounding variables. There were no differences seen in odds of prehospital systemic corticosteroid administration by race and ethnicity.
"These findings may reflect disease severity not manifested by abnormal vital signs, management, and other social factors that warrant further investigation," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
FDA Adds Fasenra Indication for Severe Asthma in Children
TUESDAY, April 16, 2024 -- The U.S. Food and Drug Administration has approved an additional indication for Fasenra (benralizumab) as an add-on maintenance treatment for patients...
SARS-CoV-2 Positivity Not Linked to New Asthma Diagnosis in Children
FRIDAY, April 12, 2024 -- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) positivity in children is not associated with an increased...
Widening of Disparities in Pollution-Attributed Health Burden Observed
THURSDAY, March 14, 2024 -- There has been a widening of racial and ethnic relative disparities in the pollution-attributable health burden within the United States, according to...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.